Frank Louis Jaksch
Co-Founder & ChairmanMr. Frank Louis Jaksch, Jr., serves as Member of Advisory Board of Yuva Biosciences, Inc. He is the Chief Executive Officer of Ayana Bio from August, 2022. He has experience in life sciences and food, beverage, and dietary supplement consumer products, building dietary supplement and food ingredient company ChromaDex from the ground up and taking the company public on Nasdaq. He serves as Chairman of the Niagen Bioscience, Inc. (formerly known as ChromaDex Corporation) since June 22, 2018 and served as its Executive Chairman since June 22, 2018 until June 30 2022. He co-founded Niagen Bioscience, Inc. (formerly known as ChromaDex Corporation) in September 1999 and served as its President. Mr. Jaksch was the Chief Executive Officer of Niagen Bioscience, Inc. (formerly known as ChromaDex Corporation) since June 11, 2012 until June 22, 2018 and served as its President since June 11, 2012. Prior to founding ChromaDex, Mr. Jaksch served as an International Subsidiaries Manager of Phenomenex. Mr. Jaksch served as the Chief Scientific Officer of Niagen Bioscience, Inc. (formerly known as ChromaDex Corporation) and served as its Chief Executive Officer since 2000. He was responsible for the Vision and Leadership of ChromaDexs operations, with key focus on the sales and marketing efforts. With General Management, Sales, Marketing and Business Development experience, he provides Strategic, Operations and Marketing Leadership to ChromaDex Inc. He provides the overall Vision and Leadership to ChromaDex group, as well as significant Technical, Sales and Marketing experience in Scientific Products, Pharmaceutical and Nutraceutical Markets. He has management experience in Analytical Chemistry, Diagnostics, Sales and Marketing and General Management experience with Global Industry leaders such as ICN Pharmaceutical and Phenomenex. He also serves on the Board of Directors for the Natural Products Association (NPA), where he also serves as the Treasurer. Mr. Jaksch was a Co-Editor of Current Opinion in Biotechnology: Analytical Biotechnology in February 2014, which highlighted new technologies for quantitative analysis of natural products. He is a Member of the American Chemistry Society, the American Herbal Products Association and the American Botanical Council. Mr. Jaksch managed the International Subsidiary and International Business Development Divisions at Phenomenex. He focused on developing New International Subsidiaries for Phenomenex. From 1993 to 1999, he setup Sales and Marketing Offices in Australia, England, Germany and New Zealand. He returned to the US from New Zealand in July 1999 and started ChromaDex in September 1999. He served as Chairman of the Board of Niagen Bioscience, Inc. (formerly known as ChromaDex Corporation) from May 2010 to October 2011. He served as Co-Chairman of the Board of Niagen Bioscience, Inc. (formerly known as ChromaDex Corporation) from February 2000 to May 2010. He has been a Director of ChromaDex Inc. since February 2002 and had been its Executive Director until June 30, 2022. He also co-authored The Handbook of Analytical Methods for Dietary Supplements with Drs. Mark Roman and Mingfu Wang, which was published by the American Pharmacists Association in June 2005. Mr. Jaksch earned a B.S. in Chemistry and Biology from Valparaiso University.
Positions
- Company NameNiagen Bioscience, Inc.Stock CodeNAGEPositionCo-Founder & ChairmanColleagues
- RNRobert N. FriedCEO & Director
- OPOzan PamirCFO & Principal Accounting Officer
- CLCarlos LopezSenior VP & General Counsel
- ASAndrew ShaoSenior Vice President of Global Regulatory & Scientific Affairs
- RDRoger D. KornbergChairman of the Scientific Advisory Board
- SDSteven D. RubinLead Independent Director
- KPKristin PatrickIndependent Director
